within Pharmacolibrary.Drugs.ATC.J;

model J01MA12_1
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.000145,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.074,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.053,
    k12             = 10.7,
    k21             = 10.7
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01MA12_1</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Levofloxacin is a broad-spectrum third-generation fluoroquinolone antibiotic, primarily used for the treatment of bacterial infections such as respiratory tract infections, urinary tract infections, and skin infections. It is approved and widely used in clinical practice today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for a single intravenous dose in healthy adult volunteers.</p><h4>References</h4><ol><li><p>Setiawan, E, et al., &amp; Roberts, JA (2022). Population pharmacokinetics and dose optimization of intravenous levofloxacin in hospitalized adult patients. <i>Scientific reports</i> 12(1) 8930–None. DOI:<a href=&quot;https://doi.org/10.1038/s41598-022-12627-1&quot;>10.1038/s41598-022-12627-1</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35624222/&quot;>https://pubmed.ncbi.nlm.nih.gov/35624222</a></p></li><li><p>Landoni, MF, &amp; Albarellos, GA (2019). Pharmacokinetics of levofloxacin after single intravenous, oral and subcutaneous administration to dogs. <i>Journal of veterinary pharmacology and therapeutics</i> 42(2) 171–178. DOI:<a href=&quot;https://doi.org/10.1111/jvp.12726&quot;>10.1111/jvp.12726</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30302775/&quot;>https://pubmed.ncbi.nlm.nih.gov/30302775</a></p></li><li><p>Urzúa, N, et al., &amp; Errecalde, C (2020). Pharmacokinetics of levofloxacin after single intravenous and oral administration, and its interaction with sucralfate in mixed-breed dogs. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 50(12) 1490–1493. DOI:<a href=&quot;https://doi.org/10.1080/00498254.2020.1793031&quot;>10.1080/00498254.2020.1793031</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32628058/&quot;>https://pubmed.ncbi.nlm.nih.gov/32628058</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01MA12_1;
